Literature DB >> 19504054

[Perioperative antibiotic prophylaxis in dermatologic surgery. Update 2009].

M Mühlstädt1, D Kulichová, C Kunte.   

Abstract

As specific data and studies concerning perioperative antibiotic prophylaxis in dermatologic surgery are scarce, recommendations to date mainly draw on findings from other medical disciplines and use them analogously. Three main factors are essential in the decision process: 1st How contaminated is the wound (or will it be)? 2nd Where is the lesion located and what kind of procedure is intended? 3rd Is the patient among the highest risk group for endocarditis? An algorithm is presented incorporating these key features. The preferred antibiotic for perioperative prophylaxis is a first generation or second generation oral cephalosporin, a beta-lactamase resistant penicillin (isoxazolyl penicillin) or amoxicillin/clavulanic acid. The prophylaxis is administered in the highest possible single dose within 2 hours before and 3 hours after surgery. Penicillin or cephalosporin can be substituted with clindamycin or erythromycin in case of known drug allergies. There is insufficient data on the pros and cons of preoperative hair removal. Should hair removal be necessary, clipping is preferred to shaving.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19504054     DOI: 10.1007/s00105-009-1719-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  15 in total

1.  The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection.

Authors:  D C Classen; R S Evans; S L Pestotnik; S D Horn; R L Menlove; J P Burke
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

2.  Prospective study of wound infections in dermatologic surgery in the absence of prophylactic antibiotics.

Authors:  Anthony J Dixon; Mary P Dixon; Deborah A Askew; David Wilkinson
Journal:  Dermatol Surg       Date:  2006-06       Impact factor: 3.398

3.  Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008.

Authors:  Tina I Wright; Larry M Baddour; Elie F Berbari; Randall K Roenigk; P Kim Phillips; M Amanda Jacobs; Clark C Otley
Journal:  J Am Acad Dermatol       Date:  2008-09       Impact factor: 11.527

4.  Risk factors for surgical-wound infection in general surgery: a prospective study.

Authors:  M Lizán-García; J García-Caballero; A Asensio-Vegas
Journal:  Infect Control Hosp Epidemiol       Date:  1997-05       Impact factor: 3.254

5.  Preventing bacterial infection by coordinating antibiotic and host activity: a time-dependent relationship.

Authors:  J F Burke
Journal:  South Med J       Date:  1977-10       Impact factor: 0.954

6.  Antimicrobial activity of lidocaine against bacteria associated with nosocomial wound infection.

Authors:  A M Parr; D E Zoutman; J S Davidson
Journal:  Ann Plast Surg       Date:  1999-09       Impact factor: 1.539

7.  Antibiotic prophylaxis for dental patients with total joint replacements.

Authors: 
Journal:  J Am Dent Assoc       Date:  2003-07       Impact factor: 3.634

8.  Bacteremia associated with toothbrushing and dental extraction.

Authors:  Peter B Lockhart; Michael T Brennan; Howell C Sasser; Philip C Fox; Bruce J Paster; Farah K Bahrani-Mougeot
Journal:  Circulation       Date:  2008-06-09       Impact factor: 29.690

Review 9.  Antibiotic prophylaxis in dermatologic surgery.

Authors:  A F Haas; R C Grekin
Journal:  J Am Acad Dermatol       Date:  1995-02       Impact factor: 11.527

10.  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.

Authors:  Walter Wilson; Kathryn A Taubert; Michael Gewitz; Peter B Lockhart; Larry M Baddour; Matthew Levison; Ann Bolger; Christopher H Cabell; Masato Takahashi; Robert S Baltimore; Jane W Newburger; Brian L Strom; Lloyd Y Tani; Michael Gerber; Robert O Bonow; Thomas Pallasch; Stanford T Shulman; Anne H Rowley; Jane C Burns; Patricia Ferrieri; Timothy Gardner; David Goff; David T Durack
Journal:  Circulation       Date:  2007-04-19       Impact factor: 29.690

View more
  1 in total

1.  [Acne inversa (hidradenitis suppurativa). From diagnosis to therapy].

Authors:  M Mühlstädt; F G Bechara; C Kunte
Journal:  Hautarzt       Date:  2013-01       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.